Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/22769
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: A cost-effectiveness analysis of heroin detoxification methods in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD)
Author: Shanahan, M.
Doran, C.
Digiusto, E.
Bell, J.
Lintzeris, N.
White, J.
Ali, R.
Saunders, J.
Mattick, R.
Gilmour, S.
Citation: Addictive Behaviors, 2006; 31(3):371-387
Publisher: Pergamon-Elsevier Science Ltd
Issue Date: 2006
ISSN: 0306-4603
1873-6327
Statement of
Responsibility: 
M.D. Shanahan, C.M. Doran, E. Digiusto, J. Bell, N. Lintzeris, J. White, R. Ali, J.B. Saunders, R.P. Mattick and S. Gilmour
Abstract: Abstract This economic evaluation was part of the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD) project. Data from four trials of heroin detoxification methods, involving 365 participants, were pooled to enable a comprehensive comparison of the cost-effectiveness of five inpatient and outpatient detoxification methods. This study took the perspective of the treatment provider in assessing resource use and costs. Two short-term outcome measures were used—achievement of an initial 7-day period of abstinence, and entry into ongoing post-detoxification treatment. The mean costs of the various detoxification methods ranged widely, from AUD $491 (buprenorphine-based outpatient); to AUD $605 for conventional outpatient; AUD $1404 for conventional inpatient; AUD $1990 for rapid detoxification under sedation; and to AUD $2689 for anaesthesia per episode. An incremental cost-effectiveness analysis was carried out using conventional outpatient detoxification as the base comparator. The buprenorphine-based outpatient detoxification method was found to be the most cost-effective method overall, and rapid opioid detoxification under sedation was the most cost-effective inpatient method
Keywords: Heroin; detoxification; cost-effectiveness analysis; NEPOD; Buprenorphine; Naltrexone
RMID: 0020060008
DOI: 10.1016/j.addbeh.2005.05.016
Description (link): http://www.elsevier.com/wps/find/journaldescription.cws_home/471/description#description
Appears in Collections:Pharmacology publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.